Samuel is a Principal at Digitalis, where he focuses on early-stage life sciences investments and company creation activities.
Prior to Digitalis, Samuel was a member of the healthcare practice at the Boston Consulting Group. He received graduate degrees from Cambridge and Oxford University as a Marshall Scholar and an A.B. in Chemistry from Harvard University.